Last updated 53 days ago
A Clinical Trial of a New Combination Treatment, Domvanalimab and Zimberelimab, Plus Chemotherapy, for People With an Upper Gastrointestinal Tract Cancer That Cannot be Removed With Surgery That Has Spread to Other Parts of the Body
1040 patients around the world
Available in Argentina, United States, Mexico
Arcus Biosciences, Inc.
5Research sites
1040Patients around the world
This study is for people with
Gastric cancer
Esophageal cancer
Gastroesophageal cancer
Requirements for the patient
From 18 Years
All Gender
Medical requirements
Sites
Av. Colón 3456, Mar del Plata, Buenos Aireshttp://iic-mardelplata.com.ar/
Calle San Francisco #1626 Local 8. Colonia Del Valle Sur. Benito Juárez. C.P. 03100. Ciudad de México
Calle 7 No 552 entre 24 A y 24 B Colonia Maya, Mérida, Yucatán
StudySTAR-221
SponsorArcus Biosciences, Inc.
Conditions
Gastric cancerEsophageal cancerGastroesophageal cancer
Requirements
From 18 YearsAll Gender
Unique study IDclinicaltrials.gov
NCT05568095
